Mutational processes in cancer preferentially affect binding of particular transcription factors

Mo Liu1,2, Arnoud Boot1,2, Alvin W T Ng1,2

  • 1Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.

Scientific Reports
|February 9, 2021
PubMed

Insights

Mutational processes can alter transcription factor (TF) binding, potentially activating oncogenic pathways. Our study reveals how specific mutational signatures impact TF binding, highlighting risks for NOTCH1 and toll-like-receptor signaling pathways.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Transcription factors (TFs) regulate gene expression through DNA binding.
  • Mutational signatures characterize DNA damage patterns from various processes.
  • Understanding how mutations affect TF binding is crucial for cancer research.

Purpose of the Study:

  • To develop a method integrating TF binding data and mutational signatures.
  • To predict which TF binding profiles are preferentially altered by mutational processes.
  • To investigate the link between mutational processes, TF binding disruption, and oncogenic pathways.

Main Methods:

  • Developed and implemented the Signature-QBiC method.
  • Integrated protein binding microarray data with mutational signatures.
  • Applied Signature-QBiC to analyze 47 mutational signatures across 582 human TFs.

Main Results:

  • Predicted preferential disruption of TF binding by specific mutational processes.
  • Identified NOTCH1 signaling pathway TFs as strongly affected by multiple mutational signatures, including UV radiation.
  • Found toll-like-receptor signaling pathways vulnerable to UV-induced disruption.

Conclusions:

  • Novel overview of mutational process effects on TF binding.
  • Demonstrated potential for mutational processes to activate oncogenic pathways by altering TF binding sites.
  • Highlights specific pathway vulnerabilities, such as NOTCH1 and TLR signaling, to mutational damage.

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
80.8K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
32.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.5K